Transperineal 125I Implantation Guided by Ultrasound: Preliminary Results of 150 Cases

  • Gerhard Schlegel
  • Klaus Lutz
Part of the Medical Radiology book series (MEDRAD)


According to the American Cancer Society (1987), 63% of all prostate are discovered while still localized within the general region of the prostate, and 83% of all patients whose tumors are diagnosed at this stage survive more than 5 years after treatment. This success is based on early diagnosis as well as on therapeutic means. Treatment alternatives include: (1) radical prostatectomy, (2) external beam radiation therapy alone, (3) interstitial implantation of the prostate gland with 125I, (4) combination of interstitial implantation and external beam radiation therapy. The indications, advantages, disadvantages, and complications of each method are summarized in Table 1.


Prostate Specific Antigen Radical Prostatectomy Prostate Gland American Cancer Society Seed Implantation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Cancer society (1987) Cancer. Facts and figures-1987. American Cancer Society, New York, p 12Google Scholar
  2. Bagshaw MA (1986) Current conflicts in the management of prostatic cancer. Int J Radiat Oncol Biol Phys 12: 1721–1727PubMedCrossRefGoogle Scholar
  3. Barringer BS (1942) Prostatic carcinoma. J Urol 47: 306–308Google Scholar
  4. Hermanek P, Scheibe O, Spiessl B, Wagner G (1987) TNM Klassifikation malgner Tumoren, 4th edn. Springer, Berlin Heidelberg New York, pp 134–136CrossRefGoogle Scholar
  5. Holm HH, Strtyer I, Hansen H, Stadil F (1981) Ultrasonically guide percutaneous interstitial implantation of iodine 125 seeds in cancer therapy. Br J Radiol 54: 665–670PubMedCrossRefGoogle Scholar
  6. Holm HH, Juul N, Pedersen JF, Hansen H, Strßyer I (1983) Transperineal 125-iodine seed implantation in prostatic cancer guided by transrectal ultrasonography J Urol 130: 283–286PubMedGoogle Scholar
  7. Scardino PT, Bretas F (1987) Interstitial radiotherapy. In: Bruce AW, Tarchtenberg J (eds) Adenocarcinoma of the prostate. Springer, Berlin Heidelberg New York, pp 145–158CrossRefGoogle Scholar
  8. Van der Werf-Messing B (1982) Radiation therapy of carcinoma of the prostate. In: Jacobi GH, Hohenfellner R (eds) Prostate cancer. Williams and Wilkins, Baltimore, pp 195–211Google Scholar
  9. Wannenmacher M, Sommerkamp H, Knüfermann H, Kuphal K (1979) Die interstitielle Strahlentherapie in der Behandlung des Prostatakarzinoms. Dtsch Arztebl 76: 1371–1378Google Scholar
  10. Whitmore WF Jr, Hilaris BS, Grabstald H (1972) Retro-pubic implantation of iodine-125 in the treatment of prostatic cancer. J Urol 108: 918–920PubMedGoogle Scholar
  11. Young HH, Fronz W (1917) Some new methods in the treatment of carcinoma of the lower genitourinary tract with radium. J Urol 1: 505–536Google Scholar
  12. Zincke H, Utz DC, Vahle PM, Taylor WF (1987) Treatment options for patients with stage D1 (T0–3 N1–3 MO) adenocarcinoma of prostate. Urology 30: 307–315PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • Gerhard Schlegel
    • 2
  • Klaus Lutz
    • 1
  1. 1.Urologische KlinikKatharinen-hospitalStuttgart 10Germany
  2. 2.Radiologische KlinikKatharinen-hospitalStuttgart 10Germany

Personalised recommendations